Premium
Lessons from early large‐scale adoption of celecoxib and rofecoxib by Australian general practitioners
Author(s) -
Kerr Stephen J,
Mant Andrea,
Horn Fiona E,
McGeechan Kevin,
Sayer Geoffrey P
Publication year - 2004
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2004.tb05939.x
Subject(s) - rofecoxib , celecoxib , scale (ratio) , medicine , business , geography , cyclooxygenase , chemistry , biochemistry , cartography , enzyme
To assess trends in the first two years of prescribing of COX-2-selective non-steroidal anti-inflammatory drugs (C2SNs) by Australian general practitioners.